Despite the positive impact of treatments that lead to viral suppression, people living with HIV face various stigmas that negatively impact their lives.
Survey finds positive HCP relationships, negative quality of life for chronic migraine patients who currently use vs. never used CGRP therapies.
A Cystic Fibrosis survey finds patients who have never used a CFTR modulator are more likely to say CF negatively impacts their overall quality of life.
Health Union has ranked among Deloitte Technology Fast 500 ™ for the second consecutive year due to exponential growth since the company started in 2010.
84% of survey respondents who experienced atopic dermatitis symptoms as kids said they were diagnosed more than 10 years ago.
A new Health Union survey finds the experiences of caregivers of people with Alzheimer’s disease differ greatly as the condition progresses.
The “Multiple Sclerosis In America 2019” survey uncovers the behaviors of people living with multiple sclerosis using a disease-modifying therapy (DMT).
For the second consecutive year, Health Union has been recognized by Inc. magazine’s annual Inc. 5000 list with a three-year growth of 469%.
People with ankylosing spondylitis who consulted four or more HCPs while seeking a diagnosis experience more difficult patient journeys.
Rompala will leverage more than two decades of experience to provide a strategic roadmap for evolving Health Union’s technological and data capabilities.